VIRIDIAN THERAPEUTICS INC's ticker is VRDN and the CUSIP is 92790C104. A total of 126 filers reported holding VIRIDIAN THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 4.13 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $485,465 | -96.2% | 31,647 | -94.1% | 0.00% | -100.0% |
| Q2 2023 | $12,668,079 | +211.2% | 532,496 | +232.8% | 0.00% | – |
| Q1 2023 | $4,071,061 | +131.1% | 160,026 | +165.4% | 0.00% | – |
| Q4 2022 | $1,761,480 | -8.9% | 60,304 | -36.0% | 0.00% | – |
| Q3 2022 | $1,934,000 | +40.3% | 94,286 | -20.8% | 0.00% | – |
| Q2 2022 | $1,378,000 | -45.4% | 119,054 | -12.7% | 0.00% | – |
| Q1 2022 | $2,522,000 | +130.1% | 136,427 | +146.3% | 0.00% | – |
| Q4 2021 | $1,096,000 | +287.3% | 55,400 | +222.1% | 0.00% | – |
| Q3 2021 | $283,000 | – | 17,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VR Adviser, LLC | 3,082,622 | $47,287,421 | 4.98% |
| COMMODORE CAPITAL LP | 2,200,000 | $33,748,000 | 3.94% |
| Paradigm Biocapital Advisors LP | 3,681,747 | $56,477,999 | 3.83% |
| Vivo Capital, LLC | 1,678,207 | $25,743,695 | 2.82% |
| Fairmount Funds Management LLC | 1,369,623 | $21,010,017 | 2.53% |
| Octagon Capital Advisors LP | 1,067,143 | $16,369,974 | 2.52% |
| ACUTA CAPITAL PARTNERS, LLC | 224,339 | $3,441,360 | 2.31% |
| Logos Global Management LP | 1,050,000 | $16,107,000 | 2.15% |
| Kopp Family Office, LLC | 214,290 | $3,287 | 2.08% |
| 5AM Venture Management, LLC | 410,000 | $6,289,400 | 1.81% |